Drug Profile
Research programme: autoimmune and inflammatory therapeutics - Pharmatrin
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pharmatrin
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammatory bowel diseases
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammatory-bowel-disease in Ireland
- 20 Oct 2009 Preclinical trials in Inflammatory bowel disease in Ireland (unspecified route)